National Institutes of Health: 

  • Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery. Budget: Up to $750,000 total for up to 3 years.  Proposal deadline: October 16, 2017; February 16, 2018. 
  • Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics. Budget: Up to $250,000 per year for up to 3 years. Proposal deadline: October 18, 2017; February 20, 2018.
  • Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50)This FOA invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a related group of cancers. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities (see the P20 opportunity below as well). The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant. LOI deadline: December 15, 2017. Full proposals due: January 25, 2018 (January 17 in OSP/BMRA). Budget: Up to $1.4 million direct costs per year for up to 5 years. 
  • Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)This FOA invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs. It is the expectation that the research programs developed by the P20 awards should be competitive with other applications for a full Specialized Programs of Research Excellence (SPORE--see above), addressing cancer health disparities as a cross-cutting research theme. LOI deadline: December 18, 2017. Full proposals due: January 18, 2018 (January 8 in OSP/BMRA). Budget: Up to $800,000 direct costs per year for up to 3 years. 
  • Immuno-Oncology Translation Network (IOTN)Four companion FOAs will support the establishment of the IOTN with the following components:
    • Cancer Immunotherapy Consortium (CIC): The CIC will be composed of organ site-specific Cancer Immunotherapy Research Projects (U01) (to be supported by RFA-CA-17-045) and Cancer Immunoprevention Research Projects (to be supported by RFA-CA-17-046). The CIC will form an integrated network of multi-disciplinary, collaborative teams with the overarching goals of accelerating the development of improved immunotherapeutic strategies capable of eliminating established cancers or preventing cancers before they occur. Approximately 10-12 U01s are expected to be awarded in FY18.
    • Data Management and Resource-Sharing Center (DMRC): The DMRC (one U24, to be supported by RFA-CA-17-047) will provide overall support, and facilitate collaboration among the adult IOTN-funded components. The DMRC will also promote scientific outreach with other Cancer Moonshot initiatives and the larger scientific community.
    • Cellular Immunotherapy Data Resource (CIDR): The CIDR (one U24, to be supported by RFA-CA-17-048) will support a data registry for collecting outcomes of patients receiving cellular immunotherapies, that could be utilized for observational studies or inform subsequent pre-clinical studies and clinical trials.
LOIs deadline: December 16, 2017. Full proposals due: January 16, 2018 (January 7 in OSP/BMRA). 

COBRE Center for Computational Biology of Human Disease:

  • CBHD Pilot Award Program: The goal is to identify and support activities of talented junior investigators working on human disease related questions that require computational analyses of complex data sets. Awardees will gain access to the Computational Biology Core of staff data scientists who will assist with data analyses. In addition, awardees may be considered for eventual recruitment to a Project Leader position in the COBRE CBHD program as existing Project Leaders attain their own independent funding and graduate from COBRE support. CBHD expects to fund two one-year projects for $25,000 each from 1/1/2018 - 12/31/2018.  Indirect costs and faculty salaries are not allowed. Deadline: October 16, 2017 by 11:45 p.m.

National Institute of General Medical Sciences:

  • Limited Submission (Brown): The NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1) is designed to support highly integrated, interdisciplinary research teams to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators. The program will award up to $1.5 million in direct costs each year for up to five years (plus up to an additional $250,000 direct costs per year for optional exploratory pilot studies for ESIs). Only one application from Brown per review cycle is permitted. Submit the requested materials by 5 p.m. on Monday, October 30, 2017 to Research_Opps@brown.edu.

IACOCCA Family Foundation: 

  • Grant applications to support innovative research projects that will lead to the cure of Type 1 Diabetes. Deadline: October 30, 2017. 

American Heart Association:

  • Collaborative Sciences Award: To foster innovative collaborative approaches to research projects that propose novel pairings of investigators from at least two broadly disparate disciplines. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two co-principal investigators and their respective disciplines. The combination and integration of studies may be inclusive of basic, clinical, population, behavioral, and/or translational research. Projects must include at least one Co-PI from a field outside cardiovascular disease and stroke. This award is also intended to foster collaboration between established and early- or mid-career investigators. Letters of intent are required. Deadline: November 1, 2017. Full Application Due:  Feb. 5, 2018. 

Center for AIDS Research: 

  • Developmental Grant Program: Support for three types of AIDS biomedical and behavioral research projects (initial AIDS research projects, pilot projects testing new or innovative ideas, and collaborative projects). Proposals addressing HIV and Substance Use or HIV and TB will be prioritized. Applications will be accepted from faculty members within the following institutions: Lifespan affiliated hospitals, Brown University, Boston University and Boston Medical Center. Deadline: November 1, 2017 by 5 p.m. 

The Institute for Precision Cardiovascular Medicine: 

Brown Office of the Vice President for Research: 

  • Salomon Faculty Research AwardsDesigned to recognize excellence in scholarship, the Richard B. Salomon Faculty Research Awards fund exceptional faculty research projects. Grants of up to $15,000 are awarded for one year. These are meant as development grants and may not be renewed, but no-cost extensions may be granted with appropriate justification. Deadline: November 20, 2017 by 5 p.m.

American Sleep Medicine Foundation: 

  • Bridge to Success Award for Early Career Investigators: Providing ‘bridge funding’ to promising sleep scientists who have applied for an entry level career development award such as a K grant from the NIH, a career development award from the VA, or equivalent and need additional time and resources. Deadline: November 27, 2017.
  • Physician Scientist Training Award: Supporting research training for physicians who wish to pursue careers as physician scientists in sleep medicine. Deadline: November 27, 2017.

Department of Defense: 

  • Breast Cancer Breakthrough Award Levels 1 & 2: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. Research Scope: Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Deadline: December 6, 2017.

The Elsa U. Pardee Foundation:

  • Grant applications to fund research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. By design, there are no limits set on the grant amount that can be requested. It must be reasonably and clearly supported by the scope of the project outlined in the application. Applications requesting more than 15% overhead are usually not considered. Deadline: December 31, 2017. 

Department of Health and Human Services: 

  • Maximizing Investigators' Research Award for Early Stage Investigators (R35): The grant will provide support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. Budget: Applications may request up to $250,000 in direct costs per year for a maximum project period of five years. Applications due October 3, 2018; and October 3, 2019 by 5 p.m. local time of applicant organization. 

National Institute of Allergy and Infectious Diseases (NIAID): 

  • Physician-Scientist Pathway to Independence Award (K99/R00): This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage. Deadlines: NIH’s Standard Due Dates and Standard AIDS Dates apply.

Diabetes Research & Wellness Foundation: 

  • Research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. Applications accepted year-round. 

National Institutes of Health & Department of Health and Human Services:

University of Vermont I-Trep Program:

Upcoming Opportunities: